RhumbLine Advisers’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$212K Buy
68,287
+310
+0.5% +$964 ﹤0.01% 3197
2025
Q1
$230K Sell
67,977
-3,520
-5% -$11.9K ﹤0.01% 3036
2024
Q4
$405K Buy
71,497
+2,354
+3% +$13.3K ﹤0.01% 2803
2024
Q3
$404K Sell
69,143
-3,318
-5% -$19.4K ﹤0.01% 2851
2024
Q2
$573K Buy
72,461
+26,014
+56% +$206K ﹤0.01% 2573
2024
Q1
$432K Buy
46,447
+3,711
+9% +$34.5K ﹤0.01% 2755
2023
Q4
$361K Sell
42,736
-304
-0.7% -$2.57K ﹤0.01% 2860
2023
Q3
$334K Buy
43,040
+1,629
+4% +$12.6K ﹤0.01% 2870
2023
Q2
$474K Buy
+41,411
New +$474K ﹤0.01% 2721
2021
Q2
Sell
-33,868
Closed -$160K 3110
2021
Q1
$160K Sell
33,868
-1,300
-4% -$6.14K ﹤0.01% 2877
2020
Q4
$251K Buy
35,168
+3,100
+10% +$22.1K ﹤0.01% 2746
2020
Q3
$342K Sell
32,068
-4,945
-13% -$52.7K ﹤0.01% 2458
2020
Q2
$467K Buy
37,013
+3,456
+10% +$43.6K ﹤0.01% 2376
2020
Q1
$307K Sell
33,557
-1,024
-3% -$9.37K ﹤0.01% 2392
2019
Q4
$482K Buy
34,581
+2,151
+7% +$30K ﹤0.01% 2377
2019
Q3
$558K Buy
32,430
+70
+0.2% +$1.2K ﹤0.01% 2278
2019
Q2
$881K Buy
32,360
+4,766
+17% +$130K ﹤0.01% 2111
2019
Q1
$528K Sell
27,594
-395
-1% -$7.56K ﹤0.01% 2313
2018
Q4
$263K Buy
27,989
+9,086
+48% +$85.4K ﹤0.01% 2602
2018
Q3
$358K Sell
18,903
-1,355
-7% -$25.7K ﹤0.01% 2425
2018
Q2
$396K Buy
20,258
+3,132
+18% +$61.2K ﹤0.01% 2409
2018
Q1
$322K Buy
17,126
+2,493
+17% +$46.9K ﹤0.01% 2399
2017
Q4
$243K Sell
14,633
-1,598
-10% -$26.5K ﹤0.01% 2550
2017
Q3
$334K Buy
16,231
+140
+0.9% +$2.88K ﹤0.01% 2509
2017
Q2
$144K Buy
16,091
+4,144
+35% +$37.1K ﹤0.01% 2847
2017
Q1
$158K Buy
11,947
+499
+4% +$6.6K ﹤0.01% 2711
2016
Q4
$146K Buy
11,448
+997
+10% +$12.7K ﹤0.01% 2748
2016
Q3
$126K Buy
+10,451
New +$126K ﹤0.01% 2781